Regulatory immune responses induced by IL-1 receptor antagonist in rheumatoid arthritis

Molecular Immunology

Volumn 49, Issue 1-2, 2011, Pages 290-296

  Niu, Xiaoyin ^a   He, Dongyi ^b   Deng, Shaohua ^a   Li, Weiyi ^a   Xi, Yebin ^a   Xie, Changyi ^a   Jiang, Ting ^b   Zhang, Jingwu Z ^a,c   Dong, Chen ^d   Chen, Guangjie ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Guanghua Rheumatology Hospital   (China)

^c Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Anakinra; IL 1 receptor Antagonist; Immune regulation; Rheumatoid arthritis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 21; METHOTREXATE; PLACEBO; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE DURATION; DRUG SAFETY; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; TH1 CELL; TH17 CELL;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CELL SEPARATION; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKINS; MALE; METHOTREXATE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 82455181862     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.08.020     Document Type: Article

References (47)

1. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 2007, 8:942-949.
2. Afzali B., Lombardi G., Lechler R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 2007, 148:32-46.
3. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
4. Boissier M.C., Assier E., Biton J., Denys A., Falgarone G., Bessis N. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 2009, 76:10-14.
5. Boissier M.C., Assier E., Falgarone G., Bessis N. Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine 2008, 75:373-375.
6. Bresnihan B., Alvaro-Gracia J.M., Cobby M., Doherty M., Domljan Z., Emery P., Nuki G., Pavelka K., Rau R., Rozman B., Watt I., Williams B., Aitchison R., McCabe D., Musikic P. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis. Rheum. 1998, 41:2196-2204.
7. Chen G. Immunotherapy of rheumatoid arthritis targeting inflammatory cytokines and autoreactive T cells. Arch. Immunol. Ther. Exp. (Warsz) 2010, 58:27-36.
8. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., Wahl S.M. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 2003, 198:1875-1886.
9. Chen Z., Tato C.M., Muul L., Laurence A., O'Shea J.J. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis. Rheum. 2007, 56:2936-2946.
10. Chung Y., Chang S.H., Martinez G.J., Yang X.O., Nurieva R., Kang H.S., Ma L., Watowich S.S., Jetten A.M., Yian Q., Dong C. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009, 30:576-587.
11. Cohen S., Hurd E., Cush J., Schiff M., Weinblatt M.E., Moreland L.W., Kremer J., Bear M.B., Rich W.J., McCabe D. Treatment of rheumatoid arthritis with Anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis. Rheum. 2002, 46:614-624.
12. Dong C., Flavell R.A. Cell fate decision: T-helper 1 and 2 subsets in immune responses. Arthritis. Res. 2000, 2:179-188.
13. Felson D.T., Anderson J.J., Boers M., Bombardier C., Furst D., Goldsmith C., Katz L.M., Lightfoot, Paulus H., Strand V. American College of Rheumatology Preliminary definition of improvement in rheumatoid arthritis. Arthritis. Rheum. 1995, 38:727-735.
14. Fu S., Zhang N., Yopp A.C., Chen D., Mao M., Chen D., Zhang H., Ding Y., Bromberg J.S. TGF-beta induces Foxp3+T-regulatory cells from CD4+CD25 - precursors. Am. J. Transplant. 2004, 4:1614-1627.
15. Gaston J.S. Cytokines in arthritis: the 'big numbers' move centre stage. Rheumatology (Oxford) 2008, 47:8-12.
16. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
17. Horai R., Nakajima A., Habiro K., Kotani M., Nakae S., Matsuki T., Nambu A., Saijo S., Kotaki H., Sudo K., Okahara A., Tanioka H., Iluse T., Ishii N., Schwartzberg P.L., Abe R., Iwakura Y. TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. J. Clin. Invest. 2004, 114:1603-1611.
18. Horai R., Sai S., Tanioka H., Nakae S., Sudo K., Okahara A., Ikuse T., Asano M., Iwakura Y. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med. 2000, 191:313-320.
19. Jiang Y., Genant H.K., Watt I., Cobby M., Bresnihan B., Aitchison R., McCabe D. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis. Rheum. 2000, 43:1001-1009.
20. Kay J., Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 2004, 43:iii2-iii9.
21. Koenders M.I., Devesa I., Marijnissen R.J., Abdollahi-Roodsaz S., Boots A.M., Walgreen B., di Padova F.E., Nicklin M.J., Joosten L.A., van den Berg W.B. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice. Arthritis. Rheum. 2008, 58:3461-3470.
22. Lamacchia C., Palmer G., Seemayer C.A., Talabot-Ayer D., Gabay C. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist. Arthritis. Rheum. 2010, 62:452-462.
23. Lee Y.R., Kweon S.H., Kwon K.B., Park J.W., Yoon T.R., Park B.H. Inhibition of IL-1beta-mediated inflammatory responses by the IkappaB alpha super-repressor in human fibroblast-like synoviocytes. Biochem. Biophys. Res. Commun. 2009, 378:90-94.
24. Lipsky P.E., van Der Heijde D.M., Clair St., Furst E.W., Breedveld D.E., Kalden F.C., Soolen J.R., Weisman J.S., Emery M., Feldmann P., Harriman M., Maini G.R.R.N. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N. Engl. J. Med. 2000, 343:1594-1602.
25. Lubberts E. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?. Cytokine 2008, 41:84-91.
26. Lubberts E., Joosten L.A., Oppers B., van den Bersselaar L., Coenen-de Roo C.J., Kolls J.K., Schwarzenberger P., van de Loo F.A., van den Berg W.B. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J. Immunol. 2001, 167:1004-1013.
27. Manel N., Unutmaz D., Littman D.R. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 2008, 9:641-649.
28. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
29. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986, 136:2348-2357.
30. Nicklin M.J., Hughes D.E., Barton J.L., Ure J.M., Duff G.W. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J. Exp. Med. 2000, 191:303-312.
31. Niu X., He D., Zhang X., Yue T., Li N., Zhang J.Z., Dong C., Chen G. IL-21 regulates Th17 cells in rheumatoid arthritis. Hum. Immunol. 2010, 71:334-341.
32. Nuki G., Bresnihan B., Bear M.B., McCabe D. European Group of Clinical Investigators, long-term safety and maintenance of clinical improvement following treatment with Anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial. Arthritis. Rheum. 2002, 46:2838-2846.
33. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715-725.
34. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Leroy H., Zhou Z., Qian T., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
35. Sato K. Th17 cells and rheumatoid arthritis: from the standpoint of osteoclast differentiation. Allergol. Int. 2008, 57:109-114.
36. Schiff M.H. Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis. Ann. Rheum. Dis. 2000, 59:i103-i108.
37. Schuna A.A. Update on treatment of rheumatoid arthritis. J. Am. Pharm. Assoc. (Wash.) 1998, 38:728-735.
38. Scott D.L., Wolfe F., Huizinga T.W. Rheumatoid arthritis. Lancet 2010, 376:1094-1108.
39. Shahrara S., Huang Q., Mandelin A.M., Pope R.M. TH-17 cells in rheumatoid arthritis. Arthritis. Res. Ther. 2008, 10:R93.
40. Singh R., Aggarwal A., Misra R. Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy. J. Rheumatol. 2007, 34:2285-2290.
41. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
42. Vincenti M.P., Coon C.I., Brinckerhoff C.E. Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts. Arthritis. Rheum. 1998, 41:1987-1994.
43. Volpe E., Servant N., Zollinger R., Bogiatzi S.I., Hupé P., Barillot E., Soumelis V. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat. Immunol. 2008, 9:650-657.
44. Wang J., van Dongen H., Scherer H.U., Huizinga T.W., Toes R.E. Suppressor activity among CD4+, CD25++ T cells is discriminated by membrane-bound tumor necrosis factor alpha. Arthritis. Rheum. 2008, 58:1609-1618.
45. Weaver C.T., Harrington L.E., Mangan P.R., Gavrieli M., Murphy K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677-688.
46. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., Basham B., Smith K., Chen T., Morel F., Lecron J.C., Kastelein R.A., Cua D.J., McClanahan T.K., Bowman E.P., de Waal Malefyt R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 2007, 8:950-957.
47. Yang L., Anderson D.E., Baecher-Allan C., Hastings W.D., Bettelli E., Oukka M., Kuchroo V.K., Hafler D.A. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008, 454:350-352.